The Effects of Normobaric Hypoxia on Blood Glucose Levels.
NCT ID: NCT01302782
Last Updated: 2013-11-25
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
WITHDRAWN
OBSERVATIONAL
2012-12-31
2013-08-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Utility Of Hemoglobin A1C For The Diagnosis Of Gestational Diabetes
NCT02273193
Influence of Intermittent Hypoxia on Glycemic Control
NCT06490900
Study of How Low Blood Sugar Affects the Way Blood Vessels Work
NCT00373854
Self Monitoring of Blood Glucose With Finger Tip vs. Alternate Site Sampling: Effect on Long Term Glycemic Control
NCT00207207
Effects of HBO on Glucose in Patients With DM
NCT04261738
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
PROSPECTIVE
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* 5 males with a BMI \< 25; 5 males with a BMI \> 25 at least 18 years of age (MOFH personnel and DoD beneficiaries).
* 5 females with a BMI \< 25; 5 females with a BMI \> 25 at least 18 years of age (MOFH personnel and DoD beneficiaries).
-5 males and/or females, at least 18 years of age, that are type 2 diabetics (MOFH personnel and DoD beneficiaries).
Exclusion Criteria
* Pulmonary disease.
* Any medications that change glucose control to include systemic steroid and diabetic medications.
* History of claustrophobia.
* Pregnant or breast feeding.
* Non-English speaking.
* Physical inability to wear/use the ROBD2
* Pulmonary disease.
* History of claustrophobia.
* Pregnant or breast feeding.
* Non-English speaking.
* Physical inability to wear/use the ROBD2
18 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Mike O'Callaghan Military Hospital
FED
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Travis Russell, M.D.
Role: PRINCIPAL_INVESTIGATOR
Mike O'Callaghan Federal Hospital/Nellis Air Force Base
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
FWH20110021H
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.